CORA MALONEY: Open Payments
NPI 1467066001 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,835 in 157 payments from 21 companies in 2025. Trend: 2023 $1,992 · 2024 $2,056 · 2025 $2,835
Food & beverage: $2,835
| Company | Payments | Amount |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 23 | $566 |
| Boston Scientific Corporation | 36 | $459 |
| ABBVIE INC. | 25 | $430 |
| PFIZER INC. | 15 | $193 |
| Neurocrine BioSciences, Inc. | 6 | $159 |
| Collegium Pharmaceutical, Inc. | 10 | $153 |
| MML US, Inc. | 3 | $144 |
| Lundbeck LLC | 9 | $138 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $86 |
| Axsome Therapeutics, Inc. | 3 | $77 |
Products named: PURIFIED CORTROPHIN GEL, WaveWriter Alpha Prime 16, QULIPTA, INGREZZA, NURTEC ODT, Belbuca, ReActiv8, VYEPTI.
Industry payments across IN — which companies pay providers there.
